Project Grant R15AR087731
Award Date 8/1/26
Completion Date 7/31/29
Dollars Obligated $545K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Normal, IL 61790, USA
Similar Awards
- Federal Grant Award Summary Washington University, through its Office of Sponsored Research Services, received a $351,000 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 1, 2025, with a completion date of July 31, 2030. The award funds basic research investigating the role of alternative splicing in facioscapulohumeral muscular...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $1.2M Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) on September 15, 2025, with a completion date of August 31, 2030. The award funds magnetic resonance (MR) research assessing the effect of neuronal nitric oxide synthase mu (NNOSM) on bioenergetics and...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $377,506 Project Grant awarded on June 5, 2026, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports research through May 31, 2028, focused on developing a first-in-class Chimeric Antigen Receptor T cell (CAR-T) therapy for Duchenne Muscular Dystrophy (DMD). This novel...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $151,040 Project Grant award dated April 15, 2026, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The project, scheduled for completion by November 30, 2028, focuses on developing muscle-optimized non-viral gene editors to improve therapeutic outcomes for Duchenne muscular...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $1.85 million Project Grant to the University of California, San Diego to conduct basic research on the role of lysine acetylation in skeletal muscle contractile function. Awarded on September 15, 2025, with completion targeted for August 31, 2028, this research project will produce scientific findings, peer-reviewed publications, and mechanistic data advancing understanding of...
- Federal Project Grant Award Summary The University of Southern California received a $352,750 Project Grant award, dated August 10, 2025, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The five-year research initiative, concluding July 31, 2030, focuses on elucidating the mechanisms and regulation of emerin self-assembly at the nuclear envelope and its implications for...
- Federal Grant Award Summary Rutgers The State University of New Jersey received a $1.09 million Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective August 7, 2025, with completion targeted for July 31, 2028. The grant funds research to develop gene therapy approaches for LAMA2-related muscular dystrophy through somatic gene amelioration using...
- Federal Project Grant Award Summary The University of Arizona received a $578,565 Project Grant awarded July 10, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) administered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The grant supports a five-year research initiative (completion date June 30, 2031) investigating the role of slow myosin binding protein-C (SMYBP-C) in the pathogenesis of distal arthrogryposis (DA), a...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Maine System a Project Grant of $471,513 on September 5, 2025 (CFDA 93.846, Arthritis, Musculoskeletal and Skin Diseases Research), with performance completion targeted for August 31, 2030. The research project investigates tissue-specific roles for muscle-matrix adhesion in neuromuscular development and homeostasis, with emphasis on understanding how...
- Federal Project Grant Award Summary The University of Michigan received a $630,434 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded on June 16, 2026, with a completion date of March 31, 2031. The award funds basic research to establish a systems-based understanding of how nuclear speckles and alternative splicing regulate muscle stem cell (MuSC)...